Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2014-08-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prospective, randomised study was designed to compare two enteral feeding methods with respect to changes in levels of leptin and ghrelin in ICU.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Bolus, Intermittent and Continuous Enteral Feeding on Blood Glucose and Feeding Intolerance in ICU Patients With Sepsis
NCT05812664
Intermittent vs Continuous Enteral Nutrition in Glycaemic Control of Diabetic ICU Patients
NCT07054476
The DINE-Normal Proof-of-concept Study
NCT06115044
Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
NCT00288743
Comparison of the Effects of Intermittent and Continuous Enteral Feeding on Glucose-Insulin Dynamics in Critically Ill Medical Patients
NCT02853799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intermittent feeding
Bolus infusion - The total daily feeding period was also 4-6 times a day.
enteral feeding by nasogastric tube.
method of administration enteral feeding by nasogastric tube.
continuous feeding
Continuous infusion - The daily desired amount was offered continuously for 20 hours a day.
enteral feeding by nasogastric tube.
method of administration enteral feeding by nasogastric tube.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enteral feeding by nasogastric tube.
method of administration enteral feeding by nasogastric tube.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* given decision on enteral feeding
Exclusion Criteria
* irreversible coma
* death or discharge before 14 days of observation
* contraindication to enteral feeding
* intolerance to the prescribed nutrients or infusion regimen
* burn
* multiple trauma
* morbid obesity
* end stage liver or renal or lung disease
* severe sepsis or septic shock
* patients with percutaneous endoscopic gastrostomy
* immunosuppressive drug use
* severe hemodynamic instability
* massive blood transfusion
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
özgür yağan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
özgür yağan
MD, assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital
Altinordu, Ordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Odu-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.